Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

EVANSVILLE, Ind. (WFIE) - At the end of July, Lilly King officially wrapped up her swimming career, racing her final meet at ...

More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, ...

It was a Tuesday with Saturday energy at the state fair. Folks came out to the fairgrounds to take advantage of a promotion ...

Abby Thomas and Grace Jones won the decisive match of the day as Blanchester held on to beat East Clinton 3-2 Wednesday in ...

Drugs to treat ADHD were linked to a reduced risk of suicidal behavior, substance misuse and criminality in the first research of its kind.

Results from the annual Indiana Reading Evaluation and Determination (IREAD) assessment show third grade literacy rates in ...

Orlando Family Stage has revealed the the continuation of its accessible performance offerings for the 2025–2026 season.

The Missouri football roster has two freshmen running backs who could be impactful as soon as this season — Marquise Davis and Brendon Haygood. The two athletes ...

Drug companies have formed a new group to present lawmakers with research on what the industry sees as the negative impacts ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) is pressing ahead in the weight-loss drug race with the launch of its Phase 2 VENTURE ...

Texas has sued pharmaceutical giant Eli Lilly for allegedly bribing and illegally inducing medical providers to prescribe its ...